Textbook outcome in ovarian cancer and its impact on survival: comparative study
- PMID: 39893428
- PMCID: PMC11786506
- DOI: 10.1186/s12957-025-03686-5
Textbook outcome in ovarian cancer and its impact on survival: comparative study
Abstract
Introduction: Patients who achieve the textbook outcome (TO) present an uneventful postoperative course. Obtaining TO has also been related to better survival in oncological patients. Information about TO in patients with peritoneal carcinomatosis from ovarian cancer who undergo surgery is very scarce. Our objective was investigate TO in patients with carcinomatosis of ovarian origin who underwent interval surgery with or without HIPEC (TOOC) and its impact on survival.
Methods: A multicenter study was performed between 2010 and 2015. Inclusion criteria were > 18 years old, with ovarian cancer and peritoneal carcinomatosis, who underwent scheduled surgery after response to neoadjuvant therapy. The criteria to establish TOOC were no major complications, no mortality, non-prolonged stay (p75:10 days), complete cytoreduction (CC-0), and no readmission.
Results: 365 patients were included, and TOOC was achieved in 204 (55.9%) patients. CC-0 cytoreduction was obtained in 312(85.5%). 7 patients (1.9%) died. 71 (19.5%) presented major complications (≥ IIIa). The readmission rate was 9.3%, and 24.9% of the patients presented a prolonged stay. The parameter with most significant negative impact on achieving TOOC was length of stay. Multivariate analysis confirmed postsurgical PCI, age, HIPEC, and time of surgery in minutes as an independent factor of TOOC. Survival analysis showed that patients who achieved TOOC had better overall survival (41 months (24.5- 67) versus 27 months (14-48.2) (p < 0.0001).
Conclusion: TO is an easy and valuable management tool for evaluating and comparing results obtained at different centers after surgery for peritoneal carcinomatosis of locally advanced ovarian cancer. Achieving TOOC benefits overall survival.
Keywords: Benchmarking; Carcinomatosis; HIPEC; Ovarian cancer; Textbook outcome.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Study approved Ethics Committee of Hospital General Universitario Dr. Balmis (Ref. CEIm: PI2023-070). The study followed the guidelines for Strenghtening the Reporting of Observational Studies in Epidemiology (STROBE). The study is registered in www.researchregistry.com/with the unique identification number (UIN) 10,306. The medical ethics committee judged that no informed consent from the patients was necessary because of the observational nature of the study without additional burden for the patient. Including the waiver of informed consent and consent for participate due the retrospective nature of the study, entailed no risk. (Page 7). Consent for publication: Not applicable. Waived for ethics Committee (Page 7). Provenance and peer review not commissioned, externally peer-reviewed. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
The role of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in ovarian carcinoma: where do we stand today? A comprehensive review and clinical insights from a leading oncology center in India.World J Surg Oncol. 2025 Jun 11;23(1):232. doi: 10.1186/s12957-025-03869-0. World J Surg Oncol. 2025. PMID: 40500703 Free PMC article. Review.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Intraperitoneal Intraoperative Chemotherapy in Advanced Ovarian Cancer: Rethinking the Future Beyond Complete Macroscopic Resection.Ann Surg Oncol. 2025 Aug;32(8):5616-5623. doi: 10.1245/s10434-025-17432-4. Epub 2025 May 17. Ann Surg Oncol. 2025. PMID: 40382456
-
Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases.World J Surg Oncol. 2025 Jul 23;23(1):297. doi: 10.1186/s12957-025-03923-x. World J Surg Oncol. 2025. PMID: 40702489 Free PMC article.
-
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD007697. doi: 10.1002/14651858.CD007697.pub3. Cochrane Database Syst Rev. 2022. PMID: 36041232 Free PMC article.
Cited by
-
Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study.J Cancer Res Clin Oncol. 2025 Aug 2;151(8):225. doi: 10.1007/s00432-025-06277-9. J Cancer Res Clin Oncol. 2025. PMID: 40751826 Free PMC article.
References
-
- Aranaz JM, Moya C. Patient safety and health care quality. Rev Calid Asist. 2011;26(6):331–2. - PubMed
-
- Kolfschoten NE, Kievit J, Gooiker GA, Van Leersum NJ, Snijders HS, Eddes EH et al. Focusing on desired outcomes of care after colon cancer resections; Hospital variations in textbook outcome. Eur J Surg Oncol. 2013;39(2):156–63. Available from: 10.1016/j.ejso.2012.10.007 - PubMed
-
- Busweiler LAD, Schouwenburg MG, van Berge Henegouwen MI, Kolfschoten NE, de Jong PC, Rozema T, et al. Textbook outcome as a composite measure in oesophagogastric cancer surgery. Br J Surg. 2017;104(6):742–50. - PubMed
-
- Carbonell-Morote S, Ortiz-Sebastián S, Estrada-Caballero JL, Gracia-Alegria E, Ruiz de la Cuesta Tapia E, Villodre C et al. Textbook Outcome in Bariatric Surgery: Evolution During 15 Years in a Referral Center. J Gastrointest Surg. 2023;27(8):1578–86. Available from: 10.1007/s11605-023-05690-0 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous